xaira.comHealthcare / BioTech & PharmaFounded: 2024Funding to Date: $1B
Xaira Therapeutics is an integrated biotechnology company utilizing AI that aims to transform the treatment of disease. The company has a mission to rethink the drug discovery and development process by honing in on machine learning research, expansive data generation, and robust therapeutic product development. Xaira Therapeutics was founded by Arvind Rajpal, David Baker, Don Kirkpatrick, Hetu Kamisetty, Joe Watchwell Watson, and Marc Tessier-Lavigne in 2024 and is headquartered in San Francisco, CA.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Xaira Therapeutics.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.